BeStock  
Stocks › Biotechnology › ELVN

Enliven Therapeutics ELVN

US equityMarket cap rank #2338Biotechnology
$46.53 +$0.12 (+0.26%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $46.53 0.00%
Open$46.05
Prev close$46.41
Day range$45.64 – $47.83
Volume933.6K
Market cap$3.42B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$74.88+60.9% vs. price
  • Buy 100%
Low $70.00Now $46.53Avg $74.88High $82.00

Recent rating changes

The last 20 actions on file set price targets from $68.00 to $82.00, averaging $74.25.

DateFirmRatingTarget
13 Nov 2026 H.C. Wainwright BUY $73.00
6 Nov 2026 JonesTrading BUY $70.00
6 Nov 2026 Guggenheim BUY $78.00
5 Nov 2026 Stifel BUY $82.00
5 Nov 2026 Barclays BUY $78.00
19 Oct 2026 H.C. Wainwright BUY $73.00
7 Oct 2026 TD Cowen BUY –
7 Oct 2026 Barclays BUY $78.00
6 Oct 2026 William Blair BUY –
5 Oct 2026 Morgan Stanley BUY $70.00
2 Oct 2026 Morgan Stanley BUY $70.00
1 Oct 2026 J.P. Morgan BUY $75.00
22 Aug 2026 William Blair BUY –
18 Aug 2026 William Blair BUY –
18 Aug 2026 Barclays BUY $78.00
17 Aug 2026 Mizuho Securities BUY $73.00
13 Aug 2026 Stifel BUY $82.00
8 Aug 2026 LifeSci Capital BUY $70.00
7 Aug 2026 LifeSci Capital BUY $70.00
6 Aug 2026 Clear Street BUY $68.00

Discussion

No comments yet — be the first to weigh in on ELVN.

Sign in to join the discussion.

Scroll to Top